Specialty Chemicals company Tatva Chintan Pharma Chem - Q1FY27 results

Revenue from operations for Q1FY27 stood at Rs 1,670.55 million, representing a YoY increase of 42.95% from Rs 1,168.64 million in Q1FY26 and a QoQ growth of 24.53% from Rs 1,341.44 million in Q4FY26. Total income reached Rs 1,698.35 million in Q1FY27 compared to Rs 1,180.19 million in Q1FY26, registering a YoY growth of 43.91%. Profit before exceptional items and tax for Q1FY27 was Rs 224.29 million, an increase of 146.45% from Rs 91.01 million in Q1FY26 and up 35.22% from Rs 165.87 million in Q4FY26. Net profit for the period (PAT) was reported at Rs 159.81 million in Q1FY27, showing a YoY growth of 140.28% compared to Rs 66.51 million in Q1FY26 and a QoQ increase of 54.84% from Rs 103.21 million in Q4FY26. Basic Earnings Per Share (EPS) for Q1FY27 stood at Rs 6.83, compared to Rs 2.84 in Q1FY26 and Rs 4.41 in Q4FY26.